Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis

被引:38
|
作者
Koelewijn, J. M. [1 ,2 ,3 ]
de Haas, M. [1 ,2 ]
Vrijkotte, T. G. M. [3 ]
van der Schoot, C. E. [1 ,2 ,3 ]
Bonsel, G. J. [3 ,4 ]
机构
[1] Sanquin Res, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Div Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
[4] Erasmus MC, Dept Hlth Policy & Management, Rotterdam, Netherlands
关键词
Prevention; RhD pregnancy immunisation; risk factors; FETOMATERNAL HEMORRHAGE; HEMOLYTIC-DISEASE; D ALLOIMMUNIZATION; D IMMUNOGLOBULIN; NEGATIVE WOMEN; NEWBORN; FETUS; PREVENTION;
D O I
10.1111/j.1471-0528.2009.02244.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To identify risk factors for Rhesus D (RhD) immunisation in pregnancy, despite adequate antenatal and postnatal anti-D prophylaxis in the previous pregnancy. To generate evidence for improved primary prevention by extra administration of anti-D Ig in the presence of a risk factor. Design Case-control study. Setting Nation-wide evaluation of the Dutch antenatal anti-D-prophylaxis programme. Population Cases: 42 RhD-immunised parae-1, recognised by first-trimester routine red cell antibody screening in their current pregnancy, who received antenatal and postnatal anti-D Ig prophylaxis (gifts of 1000 iu) in their first pregnancy. Controls: 339 parae-1 without red cell antibodies. Methods Data were collected via obstetric care workers and/or personal interviews with women. Main outcome measure Significant risk factors for RhD immunisation in multivariate analysis. Results Independent risk factors were non-spontaneous delivery (assisted vaginal delivery or caesarean section) (OR 2.23; 95% CI:1.04-4.74), postmaturity (>= 42 weeks of completed gestation: OR 3.07; 95% CI:1.02-9.02), pregnancy-related red blood cell transfusion (OR 3.51; 95% CI:0.97-12.7 and age (OR 0.89/year; 95% CI:0.80-0.98). In 43% of cases, none of the categorical risk factors was present. Conclusions In at least half of the failures of anti-D Ig prophylaxis, a condition related to increased fetomaternal haemorrhage (FMH) and/or insufficient anti-D Ig levels was observed. Hence, RhD immunisation may be further reduced by strict compliance to guidelines concerning determination of FMH and accordingly adjusted anti-D Ig prophylaxis, or by routine administration of extra anti-D Ig after a non-spontaneous delivery and/or a complicated or prolonged third stage of labour.
引用
收藏
页码:1307 / 1314
页数:8
相关论文
共 50 条
  • [31] Is it necessary to administer anti-D to prevent RhD immunisation following the transfusion of RhD positive platelet concentrates?
    Atoyebi, W
    Mundy, N
    Croxton, T
    Littlewood, TJ
    Murphy, MF
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 53 - 53
  • [32] Novel RHD Alleles and Predicting Risk for Anti-D
    Vege, Sunitha
    Velliquette, Randall W.
    Aeschlimann, Judith
    Mathur, Gagan
    Hu, Zong
    Lomas-Francis, Christine
    Westhoff, Connie M.
    [J]. TRANSFUSION, 2020, 60 : 25A - 26A
  • [33] Impact of Fetal RHD screening upon a UK hospital's practice for Routine Antenatal Anti-D Prophylaxis (RAADP)
    Li, A. M. Y.
    Economides, D.
    Mehta, A.
    Cavolli, G.
    Sekhar, M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 173 - 174
  • [34] Preventing RhD haemolytic disease of the newborn - Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis
    Lee, D
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7144): : 1611 - 1611
  • [35] Reassessment of Critical Anti-D Antibody Titer in RhD Alloimmunized Antenatal Women
    Singh, Bharat
    Chaudhary, Rajendra
    Katharia, Rahul
    [J]. LABORATORY MEDICINE, 2023, 54 (04) : 429 - 433
  • [36] Terminating routine cord blood RhD typing of the newborns to guide postnatal anti-D immunoglobulin prophylaxis based on the results of fetal RHD genotyping
    Stensrud, Monica
    Baevre, Mette Silihagen
    Alm, Inger Margit
    Wong, Ho Yi
    Herud, Ida
    Jacobsen, Barbora
    de Vos, Dijanne Dicky Jannie Anne
    Stjern, Helena Eriksson
    Sorvoll, Ingvild Hausberg
    Barane, Janne Brit
    Bagas, Tonje Espeland
    Rasmussen, Mona
    Ulvahaug, Norunn
    Wamstad, Vendula
    Tomter, Geir
    Akkok, Cigdem Akalin
    [J]. FETAL DIAGNOSIS AND THERAPY, 2023, 50 (04) : 276 - 281
  • [37] First trimester non-invasive screening for fetal RHD and targeted antenatal anti-D prophylaxis - does it work?
    Tiblad, Eleonor
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 : 53 - 54
  • [38] Resource Utilization after First Trimester Noninvasive Fetal RHD Screening for Targeted Antenatal Anti-D Prophylaxis in RhD-Negative Swedish Women
    Neovius, M.
    Tiblad, E.
    Westgren, M.
    Neovius, K.
    Wikman, A. T.
    [J]. TRANSFUSION, 2014, 54 : 18A - 19A
  • [39] DETERMINATION OF ANTI-D TITERS FOLLOWING POSTNATAL RH PROPHYLAXIS
    MAAS, DHA
    BADER, W
    HOLLE, W
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 1194 - 1195
  • [40] Following targeted routine antenatal anti-D prophylaxis, almost half of the pregnant women had undetectable anti-D prophylaxis at delivery
    Sorensen, Kirsten
    Stjern, Helena Eriksson
    Karlsen, Bente Anita Grande
    Tomter, Geir
    Ystad, Inger
    Herud, Ida
    Baevre, Mette Silihagen
    Llohn, Abid Hussain
    Akkok, Cigdem Akalin
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2022, 101 (04) : 431 - 440